Perspective of the Surviving Sepsis Campaign on the Management of Pediatric Sepsis in the Era of Coronavirus Disease 2019

Pediatr Crit Care Med. 2020 Nov;21(11):e1031-e1037. doi: 10.1097/PCC.0000000000002553.

Abstract

Severe acute respiratory syndrome coronavirus 2 is a novel cause of organ dysfunction in children, presenting as either coronavirus disease 2019 with sepsis and/or respiratory failure or a hyperinflammatory shock syndrome. Clinicians must now consider these diagnoses when evaluating children for septic shock and sepsis-associated organ dysfunction. The Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-associated Organ Dysfunction in Children provide an appropriate framework for the early recognition and initial resuscitation of children with sepsis or septic shock caused by all pathogens, including severe acute respiratory syndrome coronavirus 2. However, the potential benefits of select adjunctive therapies may differ from non-coronavirus disease 2019 sepsis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Attitude to Health
  • Betacoronavirus
  • COVID-19
  • Child
  • Coronavirus Infections / complications*
  • Critical Care / standards
  • Humans
  • Multiple Organ Failure / etiology
  • Multiple Organ Failure / therapy
  • Pandemics
  • Pediatrics / standards*
  • Pneumonia, Viral / complications*
  • Practice Guidelines as Topic*
  • Resuscitation / standards
  • SARS-CoV-2
  • Sepsis / etiology
  • Sepsis / therapy*
  • Shock, Septic / etiology
  • Shock, Septic / therapy
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Vasoconstrictor Agents